Funded by Foundation

Per Dr. Tenenbaum, the JGP provided him with the necessary framework to complete his Postdoctoral Fellowship at Duke University Medical Center and his first academic position at SUNY, where he is currently a Professor specializing in RNA Nanotechnology and Genomics. Although he has not remained in the field of hematology, his current research does intersect with many diseases, including those in the field of hematology (and specifically, hemophilia). The intersection is in relation to gene therapy technology that he is developing.

Per Dr. Singer, the JGP greatly influenced her career in research. It allowed her to focus on a research project, understand the process of asking a question/creating a hypothesis and developing (with guidance) a research plan; as well as analyze the date, present it (at NHG meeting at ASH) and write/publish it. It sparked her interest in hematology and in clinical research. She has pursued her work in the field of Pediatric Hematology and has obtained funding for research (including a K23 award). She has continued with ‘benign hematology’, focusing on Thalassemia (clinical and clinical research), as well as general hematology and hemostasis. Recently, she has become more involved in hemostasis (clinical care and sponsored studies related to bleeding/thrombosis).

Per Dr. Katzman, the Judith Graham Pool Research Fellowship in Hemophilia from the National Hemophilia Foundation, that he received in 1986, was extremely formative. This initial support was the starting point that led to 25 years of productive research in HIV/AIDS, during which he believes he made significant contributions to understanding the mechanism of retrovirus integration (and the introduction of integrase inhibitors into clinical practice for treating HIV infection was particularly gratifying). The JGP Fellowship allowed him to transition during his Infectious Diseases Fellowship in a new direction. Having worked with Dr. Michael Lederman in the Department of Medicine at Case Western Reserve University and University Hospitals of Cleveland for two years on the immune dysfunction in HIV-infected hemophiliacs, this grant allowed him to enter the basic science laboratory of Jonathan Leis in the Department of Biochemistry, where he remained for 3 years in what — in essence — was a 5-year Fellowship in Infectious Diseases. Having gained this extra training, he was then prepared to obtain an independent faculty position and he moved to the Milton S. Hershey Medical Center and Penn State College of Medicine in the Departments of Medicine and Microbiology & Immunology in 1989. He continues in this faculty position, where he has combined basic research on retroviral integration with the clinical care of persons with HIV and other infectious Diseases, though he did close his basic science lab at the end of 2011. A description of his research and career record is available at: https://profiles.psu.edu/profiles/display/111718